exp3174 has been researched along with adenosine diphosphate in 1 studies
Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) | Studies (adenosine diphosphate) | Trials (adenosine diphosphate) | Recent Studies (post-2010) (adenosine diphosphate) |
---|---|---|---|---|---|
236 | 29 | 43 | 23,989 | 498 | 3,114 |
Protein | Taxonomy | exp3174 (IC50) | adenosine diphosphate (IC50) |
---|---|---|---|
Chain A, Kinesin-like protein KIF11 | Homo sapiens (human) | 0.45 | |
Heat shock 70 kDa protein 1A | Homo sapiens (human) | 0.5 | |
Sensor protein kinase WalK | Staphylococcus aureus | 7.189 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casado, S; Farré, J; Gómez, J; Jiménez, A; López-Blaya, A; López-Farré, A; Montón, M; Núñez, A; Sánchez de Miguel, L; Zalba, LR | 1 |
1 other study(ies) available for exp3174 and adenosine diphosphate
Article | Year |
---|---|
Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antibodies, Monoclonal; Benzimidazoles; Benzoates; Binding, Competitive; Biphenyl Compounds; Blood Platelets; Dose-Response Relationship, Drug; Humans; Imidazoles; Irbesartan; Losartan; Platelet Activation; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Telmisartan; Tetrazoles; Thromboxane A2; Time Factors; Valine; Valsartan | 2000 |